BGC > Produktsuche > Ticagrelor impurity | 1882095-50-2

Description:
An impurity of Ticagrelor, which is the first reversible oral P2Y12 receptor antagonist and has favorable pharmacokinetics and pharmacodynamics, including rapid peaking of plasma levels (1.5-3 hours) and rapid onset of antiplatelet effects (within 2 hours).

• Molecular Weight:629.72

Molecular Formula:
C27H43N5O10S
Canonical SMILES:
CCCSC1=NC(=C(C(=N1)NC2CC(C3C2OC(O3)(C)C)OCCO)[N+](=O)[O-])NC4CC(C5C4OC(O5)(C)C)OCCO
InChI:
InChI=1S/C27H43N5O10S/c1-6-11-43-25-30-23(28-14-12-16(37-9-7-33)21-19(14)39-26(2,3)41-21)18(32(35)36)24(31-25)29-15-13-17(38-10-8-34)22-20(15)40-27(4,5)42-22/h14-17,19-22,33-34H,6-13H2,1-5H3,(H2,28,29,30,31)
InChIKey:
RRORRLPHCQLQIN-UHFFFAOYSA-N
Synonyms:
2,2'-(((3aR,3a'R,4S,4'S,6R,6aS,6'R,6a'S)-6,6'-((5-Nitro-2-(propylthio)pyrimidine-4,6-diyl)bis(azanediyl))bis(2,2-dimethyltetrahydro-3aH-cyclopenta[d][1,3]dioxole-6,4-diyl))bis(oxy))diethanol; B0027-284940